Quotient Investors’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$2.24M Sell
17,235
-1,818
-10% -$241K 1.54% 13
2017
Q2
$2.52M Sell
19,053
-2,000
-9% -$255K 1.79% 6
2017
Q1
$2.62M Buy
21,053
+124
+0.6% +$14.8K 1.58% 9
2016
Q4
$2.41M Buy
20,929
+900
+4% +$104K 1.52% 10
2016
Q3
$2.37M Sell
20,029
-17,079
-46% -$2.07M 1.53% 8
2016
Q2
$4.5M Sell
37,108
-8,600
-19% -$977K 2.12% 3
2016
Q1
$4.95M Sell
45,708
-3,718
-8% -$385K 1.81% 4
2015
Q4
$5.08M Sell
49,426
-56,299
-53% -$5.66M 1.95% 5
2015
Q3
$9.87M Sell
105,725
-44,950
-30% -$4.35M 2.18% 12
2015
Q2
$14.7M Sell
150,675
-41,736
-22% -$4.18M 2.01% 12
2015
Q1
$19.4M Buy
192,411
+64,925
+51% +$6.6M 2.61% 6
2014
Q4
$13.3M Buy
127,486
+13,168
+12% +$1.39M 2.74% 1
2014
Q3
$12.2M Buy
114,318
+51,400
+82% +$5.33M 2.66% 2
2014
Q2
$6.58M Sell
62,918
-251
-0.4% -$25.4K 1.43% 11
2014
Q1
$6.21M Buy
63,169
+5,037
+9% +$467K 1.41% 14
2013
Q4
$5.32M Hold
58,132
1.25% 17
2013
Q3
$5.04M Hold
58,132
1.32% 12
2013
Q2
$4.99M Buy
+58,132
New +$4.93M 1.41% 14

Other funds holding JNJ

Quotient Investors's JNJ Position: Q3 2017 in Review

Quotient Investors reduced its Johnson & Johnson (JNJ) stake by 9.5% in Q3 2017, selling an estimated $241K and leaving 17,235 shares worth $2.24M. The position accounts for 1.54% of the portfolio, ranked #13.

Quotient Investors first reported a position in JNJ in Q2 2013 and has held it in 18 quarters since. The position peaked at $19.4M in Q1 2015. 2,357 funds tracked by Wall St. Rank hold JNJ as of Q3 2017.

  • Quotient Investors held 17,235 shares of Johnson & Johnson worth $2.24M as of Q3 2017.
  • Quotient Investors sold 1,818 Johnson & Johnson shares in Q3 2017, an estimated $241K.
  • Johnson & Johnson made up 1.54% of Quotient Investors's portfolio in Q3 2017, its #13 holding.
  • Quotient Investors first reported a position in Johnson & Johnson in Q2 2013 and has held it in 18 quarters since.
  • Quotient Investors's Johnson & Johnson position peaked at $19.4M in Q1 2015.
  • 2,357 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2017.

Based on Quotient Investors's 13F filing for Q3 2017, filed 18 Oct 2017.